Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A novel and easy F xCycle ™ violet based flow cytometric method for simultaneous assessment of DNA ploidy and six‐color immunophenotyping

15 Dec 2015

Abstract excerpt

Abnormal DNA ploidy is a valuable prognostic factor in many neoplasms, especially in hematological neoplasms like B-cell acute lymphoblastic leukemia (B-ALL) and multiple myeloma (MM). Current methods of flow-cytometric (FC) DNA-ploidy evaluation are either technically difficult or limited to three- to four-color immunophenotyping and hence, challenging to evaluate DNA-ploidy in minute tumor population with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Lymphoblastic Leukemia research
Share to Acute Myeloid Leukemia Research
Share to Cancer Genomics and Diagnostics

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26671309
DOI: 10.1002/cyto.a.22803

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 25 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A novel and easy F xCycle ™ violet based flow cytometric method for simultaneous assessment of DNA ploidy and six‐color immunophenotypingPMID 26671309Read ↗

FxCycle™ Based Ploidy Correlates with Cytogenetic Ploidy in B‐Cell Acute Lymphoblastic Leukemia and Is Able to Detect the Aneuploid Minimal Residual Disease CloneSemantic proximity Read ↗

High-sensitive immunophenotyping and DNA ploidy studies for the investigation of minimal residual disease in multiple myeloma.Semantic proximity Read ↗

Simultaneous use of multiplex ligation‐dependent probe amplification assay and flow cytometric DNA ploidy analysis in patients with acute leukemiaSemantic proximity Read ↗

One-tube triple staining method for flow cytometric analysis of DNA ploidy and phenotypic heterogeneity of human solid tumors using single laser excitation.Semantic proximity Read ↗

Immunophenotypic Aberrations, DNA Content, and Cell Cycle Analysis of Plasma Cells in Patients with Myeloma and Monoclonal GammopathiesSemantic proximity Read ↗

Cytometry and DNA ploidy: clinical uses and molecular perspective in gastric and lung cancer.Semantic proximity Read ↗

Flow cytometric detection of aneuploid CD38++ plasmacells and CD19+ B-lymphocytes in bone marrow, peripheral blood and PBSC harvest in multiple myeloma patientsSemantic proximity Read ↗

Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigationSemantic proximity Read ↗

Prognostic implications of DNA aneuploidy in 156 untreated multiple myeloma patientsSemantic proximity Read ↗

Image cytometry‐based detection of aneuploidy by fluorescence in situ hybridization in suspensionSemantic proximity Read ↗

Beyond six colors: a new era in flow cytometry.Semantic proximity Read ↗

Novel approach for simultaneous evaluation of cell phenotype, apoptosis, and cell cycle using multiparameter flow cytometry.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.